Please review the QC test results indicated by icon below as well as clone information before placing your order.

Human HLA-C*04:01:01 cDNA

Human HLA-C*04:01:01 cDNA from human EBV-transformed B cell line cDNA

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.

Terms and conditions set forth by the DEPOSITOR	In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature(s) designated by the DEPOSITOR is requested (Akatsuka et al., Tissue Antigens 59, 502-511 (2002).).
Ordering	Please visit Information of Request for Distribution.[link]  Order form [Credit Card Payment]  [Bank Transfer Payment] Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]

提供案内 (日本国内) [open/close]

提供条件	利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Akatsuka et al., Tissue Antigens 59, 502-511 (2002).)。
提供依頼	手続きの詳細は、「提供申込みについて[link]」をご覧ください。 提供依頼書 [Word] 提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]

Please review the QC test results indicated by icon below as well as clone information before placing your order.

References and tips

Electronic file

Sequence	RDB02886z.seq
Remarks, protocol and/or map (gif)	RDB02886.gif

Original reference

Further references such as user reports and related articles (go to bottom)

Featured content

Sequence information

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.

Test sheet	RDB13723_A5Llp1-2.pdf

Nucleotide sequence of a portion of this resource (if available).

Primer: CMV_Forward Region: CMV pro, insert 5' Sequence file: RDB13723_A5Lla.seq
>02886_13723_A9D2_CMV-Forward_B08_02_ABI08.ab1     1 NNNNNNNNNN NNNNNNTTGN NNCNNNGGGC GGTAGGCGTG TACGGTGGGA GGTCTATATA    61 AGCAGAGCTC TCTGGCTAAC TAGAGAACCC ACTGCTTACT GGCTTATCGA AATTAATACG   121 ACTCACTATA GGGAGACCCA AGCTGGCTAG CGTTTAAACT TAAGCTTTTC TCCCCAGACG   181 CCGAGATGCG GGTCATGGCG CCCCGAACCC TCATCCTGCT GCTCTCGGGA GCCCTGGCCC   241 TGACCGAGAC CTGGGCCGGC TCCCACTCCA TGAGGTATTT CTCCACATCC GTGTCCTGGC   301 CCGGCCGCGG GGAGCCCCGC TTCATCGCAG TGGGCTACGT GGACGACACG CAGTTCGTGC   361 GGTTCGACAG CGACGCCGCG AGTCCAAGAG GGGAGCCGCG GGAGCCGTGG GTGGAGCAGG   421 AGGGGCCGGA GTATTGGGAC CGGGAGACAC AGAAGTACAA GCGCCAGGCA CAGGCTGACC   481 GAGTGAACCT GCGGAAACTG CGCGGCTACT ACAACCAGAG CGAGGACGGG TCTCACACCC   541 TCCAGAGGAT GTTTGGCTGC GACCTGGGGC CGGACGGGCG CCTCCTCCGC GGGTATAACC   601 AGTTCGCCTA CGACGGCAAG GATTACATCG CCCTGAACGA GGATCTGCGC TCCTGGACCG   661 CCGCGGACAC GGCGGCTCAG ATCACCCAGC GCAAGTGGGA GGCGGCCCGT GAGGCGGANC   721 AGCGGANAGC CTACCTGGAN GGCACGTGCG TGGAGTGGCT CCGCANATAC CTGGAGANNG   781 GGAANGAGAN GCTGCAGCGC GCGGAACACC CANNGACACA CGTGACCCAC CATCCCGTCT   841 CTGACCATGA NGNCNNCCTG ANGTGCTGGG CCNNGGGCTT CTACCCNGCG NANNTCACAC 901 TGNNCNNGNN NNNNNNNN //
Primer: BGH_rev2 Region: bGH p(A), insert 3' Sequence file: RDB13723_A5Llb.seq
>02886_13723_A5Ll_BGHrev_D03_12.ab1     1 CTGGTTACGG GGGGCCCTCT AGACTCGAGC GGCCGCGTCT CAGGCTTTAC AAGCGATGAG    61 AGACTCATCA GAGCCCTGGG CACTGTTGCT GGACGCAGCC TGAGAGCAGC TCCCTCCTTT   121 TCCACCTGAG CTCTTCCTCC TACACATCAC AACAGCCACC ATAGCTCCTA GGACAGCTAG   181 GACAGCCAGG ACAGCCAGGC CAGCAACGAT GCCCACGATG GGGATGGTGG GCTGGGAAGA   241 CGGCTTCCAT CTCAGGGTGA GGGGCTCCGG CAGCCCCTCG TGCTGAACAT GGCACGTGTA   301 TCTCTGCTCT TCTCCAGAAG GCACCACCAC AGCTGCCCAC TTCTGGAAGG TTCCATCTCC   361 TGCTGGCCTG GTCTCCACAA GCTCGGTGTC CTGAGTTTGG TCCTCCCCAT CCCACTGCCA   421 GGTCAGTGTG ATCTCCGCAG GGTAGAAGCC CAGGGCCCAG CACCTCAGGG TGGCCTCATG   481 GTCAGAGACG GGATGGTGGG TCACGTGTGT CTTTGGGTGT TCCGCGCGCT GCAGCGTCTC   541 CTTCCCGTTC TCCAGGTATC TGCGGAGCCA CTCCACGCAC GTGCCCTCCA GGTAGGCTCT   601 CCGCTGCTCC GCCTCACGGG CCGCCTCCCA CTTGCGCTGG GTGATCTGAG CCGCCGTGTC   661 CGCGGCGGTC CAGGAGCGCA GATCCTCGTT CAGGGCGATG TAATCCTTGC CGTCGTAGGC   721 GAACTGGTTA TACCCGCGGA GGAGGCGCCC GTCCGGCCCC AGGTCGCAGC CAAACATCCT   781 CTGGAGGGTG TGAGACCCGT CCTCGCTCTG GTTGTAGTAG CCGCGCAGTT TCCGCAGGTT   841 CACTCGGTCA GCCTGTGCCT GGCGCTTGTA CTTCTGTGTC TCCCGGGTCC CAATACTCCG   901 GCCCCTCCTG CTCCACCCAC GGCTCCCGCG GCTCCCCTCT TGGACTCGCG GCGTCGCTGT   961 CGAACCCGCA CGAACTGCGT GTCGTCCACG TAGCCCACTG CGATGAAGCG GGGCTCCCCG  1021 CGGCCGGGCC AGGACACGGA TGTGGAAGAA ATACCCTCAT GGGAGTGGGA GCCGGGCCCA  1081 GGTCTCGGTC AGGACAGGCC TCCCGAGGAG CAGCAAGGAT GAGGGTCGGG GCGCCCAATG 1141 AACCCGCAAT TCTTCGGGCG TCTCTGGGGG GGGAGAAAAA AGGGCC //
Primer: SV40pro_F Region: NeoR Sequence file: RDB13723_A5Llc.seq
>02886_13723_A5Ll_SV40pro_F_H05_23.ab1     1 NNNNNNNNNN NNNNNNNNNN NGNNGNNGCT TTTTTGGNNG CCTANGCTTT TGCAAAAAGC    61 TCCCGGGNNC TTGTATATCC ATTTTCGGAT CTGATCAAGA GACAGGATGA GGATCGTTTC   121 GCATGATTGA ACAAGATGGA TTGCACGCAG GTTCTCCGGC CGCTTGGGTG GAGAGGCTAT   181 TCGGCTATGA CTGGGCACAA CAGACAATCG GCTGCTCTGA TGCCGCCGTG TTCCGGCTGT   241 CAGCGCAGGG GCGCCCGGTT CTTTTTGTCA AGACCGACCT GTCCGGTGCC CTGAATGAAC   301 TGCAGGACGA GGCAGCGCGG CTATCGTGGC TGGCCACGAC GGGCGTTCCT TGCGCAGCTG   361 TGCTCGACGT TGTCACTGAA GCGGGAAGGG ACTGGCTGCT ATTGGGCGAA GTGCCGGGGC   421 AGGATCTCCT GTCATCTCAC CTTGCTCCTG CCGAGAAAGT ATCCATCATG GCTGATGCAA   481 TGCGGCGGCT GCATACGCTT GATCCGGCTA CCTGCCCATT CGACCACCAA GCGAAACATC   541 GCATCGAGCG AGCACGTACT CGGATGGAAG CCGGTCTTGT CGATCAGGAT GATCTGGACG   601 AAGAGCATCA NGGGCTCGCG CCAGCCGAAC TGTTCGCCAG GCTCAAGGCG CGCATGCCCG   661 ACGGCGANGN TCTCGTCGTG ANCCATGGCG ATGCCTGCTT GCCGAATATC ATGGNGGAAA   721 ATGNNCNGCT TTTCTGGANT CNTCGACTGN GGNCGGCTGG GTGTGGCGGA NCGCTATCNN 781 NACNTANCGT NGNCTANCCN NGANNNTGNT GNAGANCNNN NNNNNNN //

Please visit Sequencing and PCR primers for primer information.

References

Original, user report and related articles

2022.02.09

GNP_filter3_RDBDEP_html_220112.pl